Recombinant multi-species DCK protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DCK protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs.  Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents.  Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives.  DCK is clinically important because of its relationship to drug resistance and sensitivity. [provided by RefSeq, Jul 2008]
The Alternative Names of target: DCK,Dck,Deoxyadenosine kinase,Deoxycytidine kinase,Deoxyguanosine kinase,dCK

Target products collectionGo to DCK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T98089-Ag-1/ GM-Tg-hg-T98089-Ag-2 Human DCK protein Human
GM-Tg-rg-T98089-Ag-1/ GM-Tg-rg-T98089-Ag-2 Rat DCK protein Rat
GM-Tg-mg-T98089-Ag-1/ GM-Tg-mg-T98089-Ag-2 Mouse DCK protein Mouse
GM-Tg-cynog-T98089-Ag-1/ GM-Tg-cynog-T98089-Ag-2 Cynomolgus/Rhesus macaque DCK protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T98089-Ag-1/ GM-Tg-felg-T98089-Ag-2 Feline DCK protein Feline
GM-Tg-cang-T98089-Ag-1/ GM-Tg-cang-T98089-Ag-2 Canine DCK protein Canine
GM-Tg-bovg-T98089-Ag-1/ GM-Tg-bovg-T98089-Ag-2 Bovine DCK protein Bovine
GM-Tg-equg-T98089-Ag-1/ GM-Tg-equg-T98089-Ag-2 Equine DCK protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T98089-Ag-1/ GM-Tg-hg-T98089-Ag-2; GM-Tg-rg-T98089-Ag-1/ GM-Tg-rg-T98089-Ag-2;
GM-Tg-mg-T98089-Ag-1/ GM-Tg-mg-T98089-Ag-2; GM-Tg-cynog-T98089-Ag-1/ GM-Tg-cynog-T98089-Ag-2;
GM-Tg-felg-T98089-Ag-1/ GM-Tg-felg-T98089-Ag-2; GM-Tg-cang-T98089-Ag-1/ GM-Tg-cang-T98089-Ag-2;
GM-Tg-bovg-T98089-Ag-1/ GM-Tg-bovg-T98089-Ag-2; GM-Tg-equg-T98089-Ag-1/ GM-Tg-equg-T98089-Ag-2
Products Name DCK protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DCK
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DCK protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.